Looking for Topotecan found 8 matches
|
Open monograph to display formulary status |
BNF Category |
|
Topotecan
|
Malignant disease and immunosuppression - Topoisomerase I inhibitors - 08.01.05
|
|
Links Link to Drug Section Link to document |
NICE TA183: Topotecan for the treatment of recurrent and stage IVB cervical cancer (08.01.05)
|
NICE TA184: Topotecan for the treatment of relapsed small-cell lung cancer (08.01.05)
|
NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
|
NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
|
NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
|
NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.02)
|
NICE TA389: Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.03)
|
|
|